Care Pharmaceuticals acquires LaCorium Health

Pitcher Partners would like to congratulate Care Pharmaceuticals, an Australian subsidiary of Prestige Consumer Healthcare Inc, a billion dollar US- listed of healthcare group on their acquisition of LaCorium Health, a privately owned, Australian therapeutic skin care business.

Founded in Australia in 1998, LaCorium has built a portfolio of therapeutic skincare brands including Dermal Therapy®, Flexitol® and Crampeze®. With around 75% of its sales generated in Australia, the business holds a leading #1 position in lip care and #3 in foot care locally, while also expanding its reach across more than 20 countries.

Care Pharmaceuticals was advised by Pitcher Partners Sydney on the transaction.

Partner, Vinod Parasuraman, led the due diligence process alongside the Sydney Corporate Finance team and Tax Partner, Paul Marino.

Vin said, “This it is an exciting deal for both parties. It’s always rewarding to work alongside clients on transactions that showcase the strength of Australian-founded brands on the global stage”.

We congratulate Care Pharmaceuticals and Prestige Consumer Healthcare team and look forward to watching their impressive growth continue.